National, Federal and State Policy Updates: July 20, 2022
National, Federal and State Policy Updates: July 20, 2022 Spotlight on Oncology On June 27, CMS introduced the Enhancing Oncology Model, a voluntary 5-year model that refines the recently concluded Oncology Care Model. The new model focuses on transforming cancer care through value-based payments, care coordination, and emphasizing health equity. CMS will reimburse participants with […]
National, Federal and State Policy Updates: June 22, 2022
National, Federal and State Policy Updates: June 22, 2022 National Policy Update Spotlight on LGBT Health In June, the Medicaid and CHIP Payment and Access Commission (MACPAC) released an issue brief on the experiences of LGBT Medicaid beneficiaries in accessing care compared to heterosexual and cisgender individuals. They found that lesbian, gay, and bisexual (LGB) […]
National, Federal & State Policy Update: June 17, 2022
Healthcare Policy Update: June 17, 2022 National Policy Update Spotlight on Maternal Health On May 31, the American Hospital Association hosted a dialogue on the use of investment funds to support digital solutions in women and children’s health. Maria Velissaris discussed her efforts in venture capitalism focused on improving health outcomes for minority women through […]
National, Federal & State Policy Update: June 1, 2022
Healthcare Policy Update: June 1, 2022 National Policy Update Spotlight on Behavioral Health On March 23, Senators Patty Murray (D-WA) and Richard Burr (R-NC) held a hearing on addressing mental health and substance abuse disorder (SUD) issues exacerbated by the pandemic, with the goal of creating a legislative package sometime in the early summer. The […]
Limited Uptake of Biosimilars Despite Potential Cost Savings
Limited Uptake of Biosimilars Despite Potential Cost Savings: Patent Expiration and Value-Based Contracting to Drive Market Changes Summary: Biosimilars are drugs that reference a biologic and are concentrated in high-cost specialty drug markets such as oncology. Despite potential for cost savings in Medicare and other markets, uptake of biosimilars in the US has historically been […]
Oncology: Value Based Care Ideas Starting to Emerge
SCALE Education Market Research Insights Written by David Blaszczak, Senior Advisor at SCALE Healthcare Over the past decade, value-based care (VBC) models have been developed in most areas of treatment in healthcare around the U.S. However, oncology remains one of the specialties that have been slow to adopt models of value-based care. In our latest […]
SCALE Education Webinar: Healthcare CEO Toolkit for Mitigating Effects of Inflation
This webinar is for SCALE Education and SCALE Leadership Circle Members. If you are not yet a Member, please click the button to learn more and sign up today. Sign Up Today to Reserve Your Seat Join SCALE experts for insights on how to mitigate the effects of inflation. Roy BejaranoCo-Founder & CEO Jason SchifmanCo-Founder […]
10 Tips for Success in Your Executive Search
Introduction The search for leadership is complex, confidential, and time sensitive. At SCALE Talent Search, we have created a collaborative process to ensure that we are consistently one step ahead of your hiring needs and timeline. Keep reading for SCALE Talent Search’s top 10 tips for a smooth executive search process. How to Conduct an […]
SCALE Leadership Series Vol. 1
Andrew Mintz, CEO of Pinnacle Fertility In the first of a series of CEO interviews featuring healthcare services industry leaders, SCALE’s operating partners had a chance to sit down with Andrew Mintz, CEO of Pinnacle Fertility, a private equity backed platform focused on women’s health/fertility. Pinnacle Fertility is one of the nation’s fastest-growing physician-centric fertility […]
SCALE Market Research Vol. 1
I/DD Shift Towards Value Based Payment Continues; Opportunities Abound for Providers Written by David Blaszczak, Senior Advisor at SCALE Healthcare Bottom Line: Payers are implementing more value-based care programs specifically for intellectual and development disabilities (I/DD), including autism spectrum disorder. We expect there to be at least 20 states to have mandated a percentage of value-based […]